Core Insights - UnitedHealth Group's shares increased by 4% following mixed Q4 2025 results, with higher operating costs impacting year-over-year earnings despite growth from expanded domestic membership [1][11] Financial Performance - Q4 adjusted earnings per share (EPS) were $2.11, beating estimates by 1%, while revenues slightly missed consensus expectations; year-over-year earnings declined by 69.1% while revenues increased by 12.3% due to an expansion of over 415,000 domestic members [6][11] - The operating cost ratio worsened year-over-year, primarily due to charges related to employee incentives and funding for the UnitedHealth Foundation [7] Future Outlook - UnitedHealth expects a medical care ratio of 88.8% for 2026, an improvement from 89.1% last year, indicating potential for higher profitability and better cost control [2][11] - Projected revenues for 2026 are expected to exceed $439 billion, reflecting a 2% year-over-year decline due to planned right-sizing; however, the operating cost ratio is anticipated to improve due to disciplined cost management [8] - The company aims for growth across all business segments, with double-digit improvements in UnitedHealthcare and low to high single-digit growth in Optum segments for 2026 [9] Medicaid Business Concerns - A 21% reduction in Medicaid membership is anticipated for 2026, raising concerns about margin pressures due to recent U.S. government funding cuts [3][11] Investment Recommendations - Investors may consider diversified healthcare ETFs with significant exposure to UnitedHealth to capitalize on its positive outlook while mitigating risks associated with its Medicaid business [4] Analyst Reactions - Following the Q4 results, analysts from RBC Capital and UBS maintained their ratings on UnitedHealth but lowered their price targets, reflecting cautious optimism amid the mixed results [12] ETFs to Consider - iShares U.S. Healthcare Providers ETF (IHF) has net assets of $726.3 million, with UnitedHealth accounting for 20.52% of the fund; it has gained 6.7% over the past six months [13] - Vanguard Health Care ETF (VHT) has net assets of $17.3 billion, with UnitedHealth at 4.09%; it has rallied 15.9% over the past six months [14][15] - iShares U.S. Healthcare ETF (IYH) has net assets of $3.52 billion, with UnitedHealth at 4.61%; it has increased by 15.2% over the past six months [16] - Health Care Select Sector SPDR Fund (XLV) has net assets of $40.87 billion, with UnitedHealth at 4.55%; it has surged 15% over the past six months [17][18]

Core Insights - UnitedHealth Group reported second-quarter 2025 earnings, with adjusted earnings of $4.08, down from $6.80 a year ago, missing the consensus of $4.95 [1] - Revenues increased 13% year over year to $111.62 billion, slightly missing the consensus of $111.69 billion [1] Financial Guidance - The company reestablished its fiscal year 2025 guidance, projecting adjusted earnings of at least $16 per share versus a consensus of $22.33, and sales guidance of $445.5 billion to $448 billion compared to the analyst estimate of $449.5 billion [3] - Adjusted earnings are now expected to be in the range of $26.00 to $26.50 per share, down from prior guidance of $29.50 to $30.00 per share, with a consensus of $29.73 [4] Medical Cost and Operating Ratios - The full-year 2025 medical cost ratio is expected to be 89.25% +/- 25 basis points, with an operating cost ratio of 12.75% +/- 25 basis points [4] - The Q2 medical care ratio was 89.4%, an increase of 430 basis points year-over-year, while the operating cost ratio was 12.3% compared to 13.3% in the previous year [5] Segment Performance - Optum Health's 2025 revenues are expected to be between $101.1 billion and $101.6 billion, a 4% decline from 2024, with earnings from operations projected at $3 billion to $3.1 billion, below expectations of around $6.6 billion [4] - UnitedHealthcare's full-year 2025 revenues are expected to range from $344 billion to $345.5 billion, growing more than 15% over 2024, with earnings from operations expected to be between $9.0 billion and $9.3 billion [4] Patient Metrics - The number of patients served under fully accountable value-based care models is expected to increase by around 300,000 to 5 million [4] - The segment served 50 million people in Q2, an increase of 770,000 year-to-date, with the employer and individual segment seeing an increase of 400,000 year-over-year [5] Market Strategy - The company plans to be more conservative with its market footprint and may exit certain markets to manage its membership profile [6]